148 related articles for article (PubMed ID: 8302796)
1. Lithostathine, an inhibitor of CaCO3 crystal growth in pancreatic juice, induces bacterial aggregation.
Iovanna J; Frigerio JM; Dusetti N; Ramare F; Raibaud P; Dagorn JC
Pancreas; 1993 Sep; 8(5):597-601. PubMed ID: 8302796
[TBL] [Abstract][Full Text] [Related]
2. [Pancreatic lithostathine inhibitor of calcium carbonate precipitation: structure-function relationship].
Bernard JP; Takacs T; de Reggi M; Sarles H; Dagorn JC
Nephrologie; 1993; 14(6):257-9. PubMed ID: 8145882
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nucleation and crystal growth of calcium carbonate by human lithostathine.
Bernard JP; Adrich Z; Montalto G; De Caro A; De Reggi M; Sarles H; Dagorn JC
Gastroenterology; 1992 Oct; 103(4):1277-84. PubMed ID: 1397886
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic stone protein (lithostathine), a physiologically relevant pancreatic calcium carbonate crystal inhibitor?
Bimmler D; Graf R; Scheele GA; Frick TW
J Biol Chem; 1997 Jan; 272(5):3073-82. PubMed ID: 9006958
[TBL] [Abstract][Full Text] [Related]
5. Human lithostathine S2-5: a relevant inhibitor of pancreatic stone formation?
Bimmler D; Graf R; Frick T
Pancreas; 1999 May; 18(4):417-8. PubMed ID: 10231850
[No Abstract] [Full Text] [Related]
6. Purification and assay of secretory lithostathine in human pancreatic juice by fast protein liquid chromatography.
Mariani A; Mezzi G; Malesci A
Gut; 1995 Apr; 36(4):622-9. PubMed ID: 7737574
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of calcite crystal growth inhibition by the N-terminal undecapeptide of lithostathine.
Gerbaud V; Pignol D; Loret E; Bertrand JA; Berland Y; Fontecilla-Camps JC; Canselier JP; Gabas N; Verdier JM
J Biol Chem; 2000 Jan; 275(2):1057-64. PubMed ID: 10625646
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic lithostathine as a calcite habit modifier.
Geider S; Baronnet A; Cerini C; Nitsche S; Astier JP; Michel R; Boistelle R; Berland Y; Dagorn JC; Verdier JM
J Biol Chem; 1996 Oct; 271(42):26302-6. PubMed ID: 8824282
[TBL] [Abstract][Full Text] [Related]
9. The molecular characteristics of a human pancreatic acidic phosphoprotein that inhibits calcium carbonate crystal growth.
De Caro A; Multigner L; Lafont H; Lombardo D; Sarles H
Biochem J; 1984 Sep; 222(3):669-77. PubMed ID: 6487269
[TBL] [Abstract][Full Text] [Related]
10. Evidence that human kidney produces a protein similar to lithostathine, the pancreatic inhibitor of CaCO3 crystal growth.
Verdier JM; Dussol B; Casanova P; Daudon M; Dupuy P; Berthezene P; Boistelle R; Berland Y; Dagorn JC
Eur J Clin Invest; 1992 Jul; 22(7):469-74. PubMed ID: 1516594
[TBL] [Abstract][Full Text] [Related]
11. Quantification of human lithostathine by high performance liquid chromatography.
Bernard JP; Barthet M; Gharib B; Michel R; Lilova A; Sahel J; Dagorn JC; De Reggi M
Gut; 1995 Apr; 36(4):630-6. PubMed ID: 7737575
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal antibody analysis of human pancreatic juice components related to the pancreatic calculi protein].
Montalto G; Lusher M; De Caro A; Multigner L; Sarles H; Delaage M
C R Acad Sci III; 1985; 300(6):199-202. PubMed ID: 3919892
[TBL] [Abstract][Full Text] [Related]
13. Lithostathine, the presumed pancreatic stone inhibitor, does not interact specifically with calcium carbonate crystals.
De Reggi M; Gharib B; Patard L; Stoven V
J Biol Chem; 1998 Feb; 273(9):4967-71. PubMed ID: 9478942
[TBL] [Abstract][Full Text] [Related]
14. Crystallization and preliminary crystallographic study of human lithostathine.
Pignol D; Bertrand JA; Bernard JP; Verdier JM; Dagorn JC; Fontecilla-Camps JC
Proteins; 1995 Dec; 23(4):604-6. PubMed ID: 8749859
[TBL] [Abstract][Full Text] [Related]
15. [Renal lithostathine: a new protein inhibitor of lithogenesis].
Verdier JM; Dussol B; Casanova P; Daudon M; Dupuy P; Berthezène P; Boistelle R; Berland Y; Dagorn JC
Nephrologie; 1993; 14(6):261-4. PubMed ID: 8145883
[TBL] [Abstract][Full Text] [Related]
16. Quantification of human lithostathine S2-5 forms using the antibody to the N-terminal peptide region.
Yamadera K; Wada K; Goto M; Yokoyama K; Morita Y; Kitano Y; Makino I
Pancreas; 1998 May; 16(4):475-80. PubMed ID: 9598807
[TBL] [Abstract][Full Text] [Related]
17. Concentration in pancreatic juice of lithostathine.
Sarles H
Gastroenterology; 1991 Oct; 101(4):1139-40. PubMed ID: 1889708
[No Abstract] [Full Text] [Related]
18. What function for human lithostathine?: structural investigations by three-dimensional structure modeling and high-resolution NMR spectroscopy.
Patard L; Stoven V; Gharib B; Bontems F; Lallemand JY; De Reggi M
Protein Eng; 1996 Nov; 9(11):949-57. PubMed ID: 8961348
[TBL] [Abstract][Full Text] [Related]
19. Identification of immunoreactive pancreatic stone protein in pancreatic stone, pancreatic tissue, and pancreatic juice.
Yamadera K; Moriyama T; Makino I
Pancreas; 1990 May; 5(3):255-60. PubMed ID: 2111547
[TBL] [Abstract][Full Text] [Related]
20. Protein inhibitors of calcium salt crystal growth in saliva, bile and pancreatic juice.
Verdier JM; Dussol B; Berland Y; Dagorn JC
Scanning Microsc; 1993 Sep; 7(3):1017-30. PubMed ID: 8146603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
